LEXINGTON, Mass. and AMSTERDAM, Sept. 03, 2020 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that Matt Kapusta, chief executive officer at uniQure, Maria Cantor, senior vice president of investor relations and communications, and Chiara Russo, associate director of investor relations and communications, will participate in the following upcoming conferences in September: Citi`s 15th Annual BioPharma Virtual Conference, September 9 - 10, 2020 A fireside chat with research...
|